NDC 70518-3512 – Ondansetron

Ondansetron 4 mg/1 · Tablet, Orally Disintegrating · Oral

Human Prescription Drug

Product NDC70518-3512

Product details

Brand name
Ondansetron
Generic name
Ondansetron
Labeler
REMEDYREPACK INC.
Dosage form
Tablet, Orally Disintegrating
Route
Oral
Marketing category
ANDA · ANDA078152
Marketed since
September 7, 2022
Listing expires
December 31, 2027
Pharmacologic class
Serotonin-3 Receptor Antagonist

Active ingredients

Uses, dosage, side effects and warnings for Ondansetron →

Package NDC codes (6)

Package NDCDescriptionSince
70518-3512-030 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (70518-3512-0)Sep 7, 2022
70518-3512-16 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (70518-3512-1)Sep 29, 2022
70518-3512-210 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (70518-3512-2)Oct 20, 2023
70518-3512-59 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (70518-3512-5)Dec 23, 2023
70518-3512-715 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (70518-3512-7)Mar 6, 2025
70518-3512-83 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (70518-3512-8)Jul 24, 2025

Other Ondansetron products